The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Otrivine Sinusitis Relief 0.1% w/v Nasal Spray, Solution

Haleon Ireland LimitedPA0678/120/003

Main Information

Trade NameOtrivine Sinusitis Relief 0.1% w/v Nasal Spray, Solution
Active SubstancesXylometazoline hydrochloride
Dosage FormNasal spray, solution
Licence HolderHaleon Ireland Limited
Licence NumberPA0678/120/003

Group Information

ATC CodeR01AA Sympathomimetics, plain
R01AA07 xylometazoline


License statusAuthorised
Licence Issued27/02/1991
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to the general public
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version
« Back